$11.15
0.131.13%
Last update: Dec 16, 1:23 PM
Comments
Loading...
Entrada Therapeutics Stock Guidance | NASDAQ:TRDA | Benzinga
Entrada Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
FAQ
What is the most recent guidance for Entrada Therapeutics (TRDA)?
There have been no specific sales or earnings guidance reported for Entrada Therapeutics in recent months.
Browse guidance and forecast on all stocks.
